Cargando…
Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol
BACKGROUND: Two-thirds of U.S. adult women are overweight or obese. High body mass index (BMI) and adult weight gain are risk factors for a number of chronic diseases, including postmenopausal breast cancer. The higher postmenopausal breast cancer risk in women with elevated BMI is likely to be attr...
Autores principales: | Martinez, Jessica A., Chalasani, Pavani, Thomson, Cynthia A., Roe, Denise, Altbach, Maria, Galons, Jean-Philippe, Stopeck, Alison, Thompson, Patricia A., Villa-Guillen, Diana Evelyn, Chow, H-H. Sherry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950218/ https://www.ncbi.nlm.nih.gov/pubmed/27430256 http://dx.doi.org/10.1186/s12885-016-2551-3 |
Ejemplares similares
-
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer
por: Chalasani, Pavani, et al.
Publicado: (2015) -
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer
por: Segar, Jennifer M., et al.
Publicado: (2019) -
Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer
por: Brown-Glaberman, Ursa, et al.
Publicado: (2016) -
Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients
por: Martinez, Jessica A., et al.
Publicado: (2023) -
T2 mapping of the heart with high temporal and spatial resolution using a radial double inversion fast spin-echo pulse sequence with view sharing
por: Altbach, Maria, et al.
Publicado: (2012)